This is the general structure of an influenza A virion. You can reference the corresponding functions for the abbreviations (PB2, PB1, PA, HA, NP, NA, NS) used in following table from CDC.
The following swine influenza A (H1N1) sequences were submitted to NCBI and are available in GenBank:
April 27, 2009, submitted by CDC:
| PB2 | PB1 | PA | HA | NP | NA | MP | NS |
Influenza A virus | ||||||||
Influenza A virus |
| |||||||
Influenza A virus | ||||||||
Influenza A virus | ||||||||
Influenza A virus | ||||||||
Influenza A virus | ||||||||
Influenza A virus |
You can find more information by clicking following website:
In fact, CDC has pointed this out in an article "Surveillance for neuraminidase inhibitor resistance among human influenza A and B viruses circulating worldwide from 2004 to 2008." published on Antimicribial Agents and Chemotherapy, September 2008, p. 3284-3292, Vol. 52, No. 9.
Following is a table for characterization of extreme and mild outliers among A(H1N1) viruses from past seasons in 2007:
TABLE 3. Characterization of extreme and mild outliers among A(H1N1) viruses from three previous seasonsa
|
a Includes viruses collected from 1 October 2004 to 30 September 2007.
b Resistant virus.
c Mean IC50 ± SD values were calculated from data collected from at least three independent experiments.
d E, extreme; M, mild; O, oseltamivir (IC50s > 2.89 nM); Z, zanamivir (IC50s > 3.89 nM).
e Boldface type indicates a mutation in the NA active site.
f A 638-fold increase in the IC50 for oseltamivir compared to that of the matching virus A/Georgia/17/2006 (accession no. EU100630).
g A 1,616-fold increase in IC50 for oseltamivir compared to that of the matching virus A/Massachusetts/6/2006 (accession no. EU100634).
h IC50s were below the cutoff after retesting.
i Additional sequences for this virus are those of accession no. EU516198 and EU516199.
H247Y is quite resistant to Roche's Tamiflu (oseltamivir phosphate). I am not very sure if the strain found in Mexico with the same mutation H247Y. However, the news from the World Health Organization seems good for us, and, of course, for Roche...........“The information we have to far is the strain is receptive to Tamiflu,” WHO spokesman Aphaluck Bhatiasevi told Dow Jones Newswires.
沒有留言:
張貼留言